Cipla Ltd.’s consolidated net profit rose 18% in the first quarter of the current financial year, beating analysts’ estimates.
The drugmaker posted a profit of Rs 1,298 crore in the quarter-ended June, according to an exchange filing on Friday. That compares with the Rs 1,198-crore consensus estimate of analysts tracked by Bloomberg.
